| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT07227298 Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in… |
Trial sites expanded: 32 -> 45 locations |
| 2026-05-28 | NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer |
Primary endpoint(s) modified |
| 2026-05-28 | NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer |
Trial sites reduced: 338 -> 334 locations |
| 2026-05-28 | NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer |
date change Completion pushed: 2028-03-11 -> 2028-05-17 |
| 2026-05-20 | NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer |
date change Primary completion pushed: 2026-03-12 -> 2026-05-18 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06758401 | This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug… | Non-Small Cell Lung Cancer | Recruiting |
| NCT06012435 | A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07227298 | Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in… | Advanced/Metastatic Non-Small Cell Lung Cancer | Recruiting |
| Phase 1 | |||
| NCT04389632 | A Study of Sigvotatug Vedotin in Advanced Solid Tumors | Carcinoma, Non-Small Cell Lung | Recruiting |